
浏览全部资源
扫码关注微信
纸质出版日期:2018
移动端阅览
钟云青, 许光兰, 王秀峰, 等. 款冬花散治疗支气管扩张症急性加重期痰热郁肺证的临床观察[J]. 中国实验方剂学杂志, 2018,24(20):169-174.
ZHONG Yun-qing, XU Guang-lan, WANG Xiu-feng, et al. Effect of Kuandonghua San for Acute Exacerbation of Bronchiectasis with Phlegm-heat Stagnation Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(20): 169-174.
钟云青, 许光兰, 王秀峰, 等. 款冬花散治疗支气管扩张症急性加重期痰热郁肺证的临床观察[J]. 中国实验方剂学杂志, 2018,24(20):169-174. DOI: 10.13422/j.cnki.syfjx.20181818.
ZHONG Yun-qing, XU Guang-lan, WANG Xiu-feng, et al. Effect of Kuandonghua San for Acute Exacerbation of Bronchiectasis with Phlegm-heat Stagnation Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(20): 169-174. DOI: 10.13422/j.cnki.syfjx.20181818.
目的:观察款冬花散治疗支气管扩张症急性加重期痰热郁肺证患者的临床疗效。方法:将符合条件的100例患者采用随机数字表法分成治疗组、对照组各50例。治疗组患者采用常规西医治疗联合服用款冬花散,对照组患者单纯采用常规西医治疗,两组疗程均为7 d,比较两组患者的临床症状评分、中医证候疗效、血炎症指标水平、血气分析及不良反应。结果:与本组治疗前比较,两组患者治疗后的临床症状评分(咳嗽、痰量、痰色、痰质、口渴、便干、尿黄)均显著降低,且治疗组显著低于对照组(P<0.01);治疗组患者总有效率为92%,对照组为80%,治疗组总有效率高于对照组(P<0.01);与本组治疗前比较,治疗后两组患者血炎症指标水平(白细胞计数、中性粒细胞数、粒淋比、血沉、快速C反应蛋白及降钙素原)均明显降低,且治疗组显著低于对照组(P<0.01);与本组治疗前比较,治疗后两组患者在血气分析血氧分压(PaO2),血二氧化碳分压(PaCO2)方面均有所改善,且治疗组显著优于对照组(P<0.01)。在试验过程中,治疗组中有2例患者出现轻微腹泻,经对证处理后症状好转,不影响后续的治疗。结论:在常规西医治疗基础上,加用款冬花散能明显改善支气管扩张症急性加重期痰热郁肺证患者的临床症状,提高中医证候疗效,减少血炎症指标水平,改善血气分析指标,疗效更好,值得在临床上推广使用。
Objective: To observe the clinical efficacy of Kuandonghua San for the treatment of acute exacerbation of bronchiectasis with the phlegm-heat stagnation syndrome.Method: A total of 100 eligible patients were randomly divided into treatment group and control group through random number table
50 cases in each group. The patients in treatment group were treated with conventional western medicine and oral Kuandonghua San
while the patients in control group were only treated with conventional western medicine. The treatment was seven days in both groups.Clinical symptom and sign scores
curative effect of traditional Chinese medicine (TCM) syndrome
blood inflammatory markers
blood gas analysis and adverse drug reactions were evaluated and compared between two groups.Result: As compared with the conditions before treatment
clinical symptom and sign scores (degree of cough
sputum volume
sputum color
sputum nature
degree of thirst
degree of constipation and degree of urine color) were decreased significantly after treatment in both groups
and those scores in treatment group were significantly lower than those in the control group (P<0.01). The total effective rate was 92% in treatment group
higher than 80% in control group (P<0.01). As compared with the levels before treatment
the levels of blood inflammatory markers (white blood cell count
neutrophil count
neutrophil to lymphocyte ratio
erythrocyte sedimentation rate
rapid C reactive protein
and procalcitonin) were significantly decreased after treatment in both groups
and the levels in treatment group were lower than those in the control group (P<0.01). In addition
both groups showed improvement in blood-gas analysis (the partial pressure of oxygen and partial pressure of carbon dioxide) after treatment in both groups
and the effect was more obvious in treatment (P<0.01). Mild diarrhea occurred in two patients of the treatment group
but was completely recovered after proper medical treatment
without affecting the subsequent treatment.Conclusion: Conventional western medicine combined with Kuandonghua San can significantly improve the clinical symptoms of patients
increase the the total effective rate
reduce the levels of blood inflammatory markers
and improve blood-gas analysis parameters. It may be an effective treatment for patients with acute exacerbation of bronchiectasis with the phlegm-heat stagnation syndrome
which is worthy of clinical popularization and application.
0
浏览量
8
下载量
5
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621